Alfresa Holdings Corporation (ARHCF)
Alfresa Holdings Corporation operates in the Medical - Distribution industry of the Healthcare sector, headquartered in Tokyo, SA, JP. The stock last traded at $14.00, up 0.00% on the session, giving a market capitalisation of $2.46B. On trailing twelve-month figures it carries a trailing P/E of 11.05, a net margin of 1.3%. Its beta of 0.08 implies it has historically moved less than the broad market.
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.
Alfresa Holdings Corporation is most often compared with the following Healthcare names: